| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/26/2012 | CA2815467A1 Manufacturing of small film strips |
| 04/26/2012 | CA2815321A1 Methods of increasing solubility of poorly soluble compounds and methods of making and using formulations of such compounds |
| 04/26/2012 | CA2815145A1 Metal ion nanoclusters |
| 04/26/2012 | CA2815097A1 Human multipotent embryonic stem cell-like progenitor cells |
| 04/26/2012 | CA2814975A1 Topical gel composition |
| 04/26/2012 | CA2814952A1 Brimonidine gel compositions and methods of use |
| 04/26/2012 | CA2814840A1 Sustained-release formulation for injection |
| 04/26/2012 | CA2814805A1 Ready to use ketorolac formulations |
| 04/26/2012 | CA2814624A1 Process for making multiparticulate gastroretentive dosage forms |
| 04/26/2012 | CA2814577A1 Use of storage stable viscous phospholipid depot to treat wounds |
| 04/26/2012 | CA2814103A1 Pharmaceutical topical composition of mupirocin |
| 04/26/2012 | CA2813016A1 Liquid pharmaceutical composition for the delivery of active ingredients |
| 04/26/2012 | CA2812891A1 Use of mexiprostil in the treatment of inflammatory bowel disease and/or of irritable bowel syndrome |
| 04/25/2012 | EP2444425A1 1:1, 2:1 or 3:1 complex consisting of a cyclodextrin or cyclodextrin derivative and a halogenated ether, production therof and use therof as soporific |
| 04/25/2012 | EP2444094A1 Mangiferin-berberine salt, manufacturing method and use thereof |
| 04/25/2012 | EP2444089A2 Anhydrous compositions useful for attaining enhanced sexual wellness |
| 04/25/2012 | EP2444087A1 Pharmaceutical composition having improved solubility |
| 04/25/2012 | EP2444080A2 Stable Pharmaceutical Drug Aerosols |
| 04/25/2012 | EP2444076A1 Fast-dissolving/disintegrating film preparation having high proportion of active agent |
| 04/25/2012 | EP2444075A2 Self-supporting films for delivery of therapeutic agents |
| 04/25/2012 | EP2444074A2 Methods of forming self-supporting films for delivery of therapeutic agents |
| 04/25/2012 | EP2444073A2 Methods of forming self-supporting films for delivery of therapeutics agents |
| 04/25/2012 | EP2444072A2 Non-mucoadhesive film dosage forms |
| 04/25/2012 | EP2444071A1 Minicapsule formulations |
| 04/25/2012 | EP2444070A1 Tablets |
| 04/25/2012 | EP2444069A1 Controlled release compositions |
| 04/25/2012 | EP2444068A1 Brimonidine gel composition |
| 04/25/2012 | EP2444067A1 Anhydrous gel comprising mupirocin |
| 04/25/2012 | EP2444066A2 System and method for satellite drug delivery |
| 04/25/2012 | EP2444065A1 Sustained release drug delivery systems comprising a water soluble therapeutic agent and a release modifier |
| 04/25/2012 | EP2444064A1 Process for making multiparticulate gastroretentive dosage forms |
| 04/25/2012 | EP2444063A1 Liquid pharmaceutical compositions for the delivery of active ingredients |
| 04/25/2012 | EP2442828A1 Novel manner of administering allergen in allergen specific immunotherapy |
| 04/25/2012 | EP2442821A1 Safe desmopressin administration |
| 04/25/2012 | EP2442813A1 A medicinal anti acne cream comprising chitosan and a process to make it |
| 04/25/2012 | EP2442812A1 Time-release and micro-dose formulations for topical application of estrogen and estrogen analogs or other estrogen receptor modulators in the treatment of dry eye syndrome, and methods of preparation and application |
| 04/25/2012 | EP2442811A1 Theobromine for the treatment of cough |
| 04/25/2012 | EP2442805A1 Nanodispersion of a drug and process for its preparation |
| 04/25/2012 | EP2442800A2 Nanoparticle and polymer formulations for thyroid hormone, analogs, antagonists, and formulations and uses thereof |
| 04/25/2012 | EP2442799A2 Solid pharmaceutical composition comprising rivaroxaban |
| 04/25/2012 | EP2442798A1 Lyophilized formulations for small modular immunopharmaceuticals |
| 04/25/2012 | EP2442797A1 Dendrimer based nanodevices for therapeutic and imaging purposes |
| 04/25/2012 | EP2442796A2 Nanoparticulate candesartan cilexetil compositions, process for the preparation thereof and pharmaceutical compositions containing them |
| 04/25/2012 | EP2442795A2 Nanoparticulate olmesartan medoxomil compositions, process for the preparation thereof and pharmaceutical compositions containing them |
| 04/25/2012 | EP2442794A1 Nanoparticulate telmisartan compositions and process for the preparation thereof |
| 04/25/2012 | EP2442793A1 Nanostructured sildenafil base, its pharmaceutically acceptable salts and co-crystals, compositions of them, process for the preparation thereof and pharmaceutical compositions containing them |
| 04/25/2012 | EP2442792A2 Lipid formulated dsrna targeting the pcsk9 gene |
| 04/25/2012 | EP2442791A1 Dosage forms of apixaban |
| 04/25/2012 | EP2442790A1 Aqueous pharmaceutical compositions containing borate-polyol complexes |
| 04/25/2012 | EP2442789A1 Stable nanoparticulate drug suspension |
| 04/25/2012 | EP2442750A2 Solid forms for tissue repair |
| 04/25/2012 | EP2442749A1 Solid forms for tissue repair |
| 04/25/2012 | EP2442668A1 Buffered gum base for high ph release |
| 04/25/2012 | EP2178519B1 Nanoparticles comprising a non-ionizable polymer and an anionic cellulosic polymer |
| 04/25/2012 | EP2151239B1 Hydrochloric piperphentonamine freeze-dried powder injection, preparation methods and uses thereof |
| 04/25/2012 | EP2146727B1 High viscosity macromolecular compositions for treating ocular conditions |
| 04/25/2012 | EP1968538B1 Pharmaceutical compositions comprising cyclosporin |
| 04/25/2012 | EP1937327B1 Natural biodegradable matrices and uses thereof |
| 04/25/2012 | EP1706150B1 Stable growth hormone liquid formulation |
| 04/25/2012 | EP1658079B1 Multivitamin syrup for children or young adults |
| 04/25/2012 | EP1441785B1 Improved method for generating an aerosol |
| 04/25/2012 | EP1381432B9 HSA-free formulations of interferon-beta |
| 04/25/2012 | EP1030652B1 Production of multivesicular liposomes |
| 04/25/2012 | EP1014953B1 Formulations for hydrophobic pharmaceutical agents |
| 04/25/2012 | CN202198868U 治疗心经组织疾病的中药浆及包装 Treatment of cardiovascular medicine through tissue disease pulp and packaging |
| 04/25/2012 | CN202198866U 治疗大肠经组织疾病的中药浆及包装 After treatment of colorectal tissue disease medicine pulp and packaging |
| 04/25/2012 | CN1929817B 包含特定的p物质拮抗剂的微乳制剂 Contains a specific substance p antagonists microemulsion |
| 04/25/2012 | CN1921878B 属于Bcl-2家族的蛋白和其片段,和它们在癌症患者中的用途 Belonging to the Bcl-2 family of proteins and their fragments, and their use in cancer patients |
| 04/25/2012 | CN1852862B 一种羟基磷灰石磷酸钙粒子,其制备方法及其用途 One hydroxy apatite calcium phosphate particles, methods for their preparation and use thereof |
| 04/25/2012 | CN1278733B Viscous compositions containing carbon dioxide |
| 04/25/2012 | CN102428096A Cell membrane-permeable peptides |
| 04/25/2012 | CN102427847A Device and methods for enhanced multi-delivery of biologically active substances into an organism and to prevent local irritation |
| 04/25/2012 | CN102427821A Compositions and methods for treatment of hemorrhage |
| 04/25/2012 | CN102427815A 使用氟喹诺酮类治疗肺部细菌感染的方法 The use of fluoroquinolones in the treatment of pulmonary bacterial infection method |
| 04/25/2012 | CN102427806A Transdermal pharmaceutical preparation and administration of tirofiban |
| 04/25/2012 | CN102427805A 固体医药组合物及其制造方法 The solid pharmaceutical composition and a method of manufacturing |
| 04/25/2012 | CN102427804A 降低胆固醇水平的脂质体 Lower cholesterol levels in liposomes |
| 04/25/2012 | CN102427802A 使用磺胺嘧啶银和壳聚糖制备的药用乳膏以及其制备方法 The use of silver sulfadiazine and chitosan medicinal creams and methods for their preparation |
| 04/25/2012 | CN102427801A 使用硫酸新霉素b乳膏和壳聚糖制备的药用乳膏以及其制备方法 Use of neomycin sulfate and chitosan prepared b cream pharmaceutical creams and their preparation |
| 04/25/2012 | CN102427800A 将活性剂优先分配到损伤部位的组合物和方法 The active agent is preferentially allocated to the damaged site of the compositions and methods |
| 04/25/2012 | CN102427795A 含有聚胍*化合物的口腔组合物及其制备和使用方法 * Poly guanidine compound and preparation of oral compositions and methods of use contain |
| 04/25/2012 | CN102427782A 双层和单层剂型 Double and single dosage form |
| 04/25/2012 | CN102424698A Modified 2' and 3' -nucleoside produgs for treating flaviridae infections |
| 04/25/2012 | CN102423493A 一种可高效高特异灭杀乳腺癌细胞的药物 One kind can efficiently kill human breast cancer cells highly specific drug |
| 04/25/2012 | CN102423490A Nano-hybrid of brufen and hydrotalcite-like and preparation method thereof |
| 04/25/2012 | CN102423488A 一种治疗带状疱疹的药物组合物 A method of treating herpes zoster in a pharmaceutical composition |
| 04/25/2012 | CN102423484A 一种稳定的西曲瑞克药物组合物及其制备方法 Cetrorelix a stable pharmaceutical composition and its preparation method |
| 04/25/2012 | CN102423483A 一种复方雷米普利纳米乳抗高血压药物 A COMPOUND ramipril nanoemulsion antihypertensives |
| 04/25/2012 | CN102423482A 复方氨氯地平赖诺普利片的制备方法 Preparation of compound amlodipine lisinopril tablets |
| 04/25/2012 | CN102423477A 肾、胃两经非解表中药注射液及生产方法 Kidney, stomach two non-relieving medicine by injection and production methods |
| 04/25/2012 | CN102423476A 肾、膀胱两经非解表中药注射液及生产方法 Kidney, bladder, two non-relieving medicine by injection and production methods |
| 04/25/2012 | CN102423475A 脾、肺两经非解表中药注射液及生产方法 Spleen, lung, two non-relieving medicine by injection and production methods |
| 04/25/2012 | CN102423473A 肺经非解表中药注射液及生产方法 Lung non-relieving medicine injection and production methods |
| 04/25/2012 | CN102423472A 胆、肺两经非解表中药注射液及生产方法 Gall bladder, lung, two non-relieving medicine by injection and production methods |
| 04/25/2012 | CN102423471A 心、胃两经非解表中药注射液及生产方法 Heart, stomach two non-relieving medicine by injection and production methods |
| 04/25/2012 | CN102423470A 心经非解表中药注射液及生产方法 Heart Sutra Non-relieving medicine injection and production methods |
| 04/25/2012 | CN102423469A 牙疼止痛软棉膏 Toothache pain soft cotton cream |
| 04/25/2012 | CN102423466A Pain relief tincture |
| 04/25/2012 | CN102423463A 肝、心两经非解表中药注射液及生产方法 Liver, heart and two non-relieving medicine by injection and production methods |
| 04/25/2012 | CN102423462A 胆、肾两经非解表中药注射液及生产方法 Gallbladder, kidney two non-relieving medicine by injection and production methods |